- Home
- HQI vs ARMP Comparison
HQI vs ARMP Comparison
Compare HQI & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- ARMP
- Stock Information
- Founded
- HQI 2002
- ARMP N/A
- Country
- HQI United States
- ARMP United States
- Employees
- HQI N/A
- ARMP N/A
- Industry
- HQI Professional Services
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HQI Consumer Discretionary
- ARMP Health Care
- Exchange
- HQI Nasdaq
- ARMP Nasdaq
- Market Cap
- HQI 140.2M
- ARMP 125.7M
- IPO Year
- HQI N/A
- ARMP N/A
- Fundamental
- Price
- HQI $8.35
- ARMP $4.99
- Analyst Decision
- HQI Buy
- ARMP Strong Buy
- Analyst Count
- HQI 1
- ARMP 1
- Target Price
- HQI $13.00
- ARMP $9.00
- AVG Volume (30 Days)
- HQI 12.1K
- ARMP 725.8K
- Earning Date
- HQI 11-06-2025
- ARMP 11-12-2025
- Dividend Yield
- HQI 2.85%
- ARMP N/A
- EPS Growth
- HQI N/A
- ARMP N/A
- EPS
- HQI 0.17
- ARMP N/A
- Revenue
- HQI $32,610,000.00
- ARMP $6,868,000.00
- Revenue This Year
- HQI N/A
- ARMP $8.43
- Revenue Next Year
- HQI $1.38
- ARMP N/A
- P/E Ratio
- HQI $48.23
- ARMP N/A
- Revenue Growth
- HQI N/A
- ARMP 84.67
- 52 Week Low
- HQI $8.04
- ARMP $0.90
- 52 Week High
- HQI $15.75
- ARMP $16.34
- Technical
- Relative Strength Index (RSI)
- HQI 36.35
- ARMP 60.08
- Support Level
- HQI $8.38
- ARMP $3.40
- Resistance Level
- HQI $8.90
- ARMP $13.75
- Average True Range (ATR)
- HQI 0.41
- ARMP 1.14
- MACD
- HQI -0.01
- ARMP 0.20
- Stochastic Oscillator
- HQI 24.41
- ARMP 17.82
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.